# Assessment of the Impact of Gadolinium Injection on the Measurement of the QSM Signal

> **NCT04906941** · — · COMPLETED · sponsor: **Fondation Ophtalmologique Adolphe de Rothschild** · enrollment: 73 (actual)

## Conditions studied

- White Matter Disease

## Interventions

- **DEVICE:** MRI

## Key facts

- **NCT ID:** NCT04906941
- **Lead sponsor:** Fondation Ophtalmologique Adolphe de Rothschild
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-21
- **Primary completion:** 2023-07-19
- **Final completion:** 2023-07-19
- **Target enrollment:** 73 (ACTUAL)
- **Last updated:** 2026-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04906941

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04906941, "Assessment of the Impact of Gadolinium Injection on the Measurement of the QSM Signal". Retrieved via AI Analytics 2026-07-29 from https://api.ai-analytics.org/clinical/NCT04906941. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*